Tsuruha Holdings (TSE:3391) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3391 Tsuruha Holdings Inc TSE:3391
48 GF Score
Price 円2,588.00
GF Value 円1,582.78
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Tsuruha Holdings Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSE:3391
48GF Score
Tsuruha Holdings Inc TSE:3391
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tsuruha Holdings (TSE:3391) Overvalued in 2026?

Based on GuruFocus' analysis, Tsuruha Holdings stock appears to be overvalued. The current stock price of 円2,588.00 is trading 63.5% above its estimated GF Value™ of 円1,582.78. GuruFocus considers Tsuruha Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3391:

  • Dividends Received:
  • GF Value™: 円1,582.78 vs. price of 円2,588.00 (63.5% above fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the TSE:3391 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tsuruha Holdings Business Description

Address Kita 24-jo Higashi 20-chome, Higashi-ku, Sapporo, JPN, 065-0024
Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. It also provides blood testing services, disease prevention solutions, and at-home drug delivery services.
48GF Score

Get the complete analysis for TSE:3391

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,588.00
Price
円1,582.78
GF Value